Invention Grant
![Anti-HBVtetrahydroisoxazolo[4,3-c]pyridine compounds](/docs/US/2023-02-07/US11572372B2/abs.jpg.600x600.jpg)
- Patent Title: Anti-HBVtetrahydroisoxazolo[4,3-c]pyridine compounds
-
Application No.: US16764129Application Date: 2018-11-16
-
Publication No.: US11572372B2Publication Date: 2023-02-07
- Inventor: Lifang Wu , Fei Sun , Jinhua Du , Charles Z. Ding , Shuhui Chen , Xiquan Zhang , Hongjiang Xu , Ling Yang
- Applicant: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. , MEDSHINE DISCOVERY INC.
- Applicant Address: CN Lianyungang; CN Jiangsu
- Assignee: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.,MEDSHINE DISCOVERY INC.
- Current Assignee: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.,MEDSHINE DISCOVERY INC.
- Current Assignee Address: CN Lianyungang; CN Jiangsu
- Agency: Kilpatrick Townsend & Stockton LLP
- Priority: CN201711138922.9 20171116,CN201810339723.2 20180416
- International Application: PCT/CN2018/115857 WO 20181116
- International Announcement: WO2019/096241 WO 20190523
- Main IPC: C07D498/04
- IPC: C07D498/04 ; A61P31/20
![Anti-HBVtetrahydroisoxazolo[4,3-c]pyridine compounds](/abs-image/US/2023/02/07/US11572372B2/abs.jpg.150x150.jpg)
Abstract:
Disclosed are a class of anti-HBV tetrahydroisoxazolo[4,3-c]pyridine compounds and pharmaceutically acceptable salts thereof or isomers thereof, the compounds being represented by the formula (I).
Public/Granted literature
- US20200377517A1 ANTI-HBVTETRAHYDROISOXAZOLO[4,3-C]PYRIDINE COMPOUNDS Public/Granted day:2020-12-03
Information query
